We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Moving Ions Around Corners To Revolutionize Disease Detection and Biotherapeutic Development
Industry Insight

The study of proteins, lipids, metabolites and other related molecules are invaluable in early disease detection and biotherapeutic development. An innovative separation technology borne out of a US Federal Laboratory, known as structures for lossless ion manipulation, is helping scientists to achieving this.

Read More

Metagenomics As a Tool To Diagnose and Understand COVID-19
Industry Insight

To learn how clinical metagenomics can be used as a tool to diagnose and understand pathogens such as SARS-CoV-2, Technology Networks recently spoke with Robert Schlaberg, co-founder and CMO of IDbyDNA.

Read More

Pathology Post COVID-19
Industry Insight

To learn more about the impact the COVID-19 pandemic is having on pathology, what the future of pathology might look like, and how digital pathology could help to ease some of the challenges, we spoke to Mark Lloyd, Founder and Executive Vice President of Inspirata.

Read More

Taking a Closer Look at Trends in Microscopy
Industry Insight

With advances in cellular and tissue-based imaging, researchers are able to peel back the layers on new challenges and test hypotheses to solve more problems. We heard about some of the advancements being made in the field of confocal microscopy.

Read More

Diagnosing Vitamin B12 Deficiency Anemia
Industry Insight

Beckman Coulter has recently expanded their range of tools for anemia diagnosis, with the launch of the Access Active-B12 Assay. We spoke to Heather Read-Harper, European Senior Manager for Immunoassay and Clinical Chemistry at Beckman Coulter, to learn more about the assay and the advantages of detecting Active-B12.

Read More

Testing for SARS-CoV-2 Using Fingerprint Sweat
Industry Insight

Intelligent Fingerprinting and Imperial College London are working together to develop a rapid, non-invasive test for SARS-CoV-2, using a fingerprint-based method. To learn more about the project and the benefits a fingerprint test could offer, we spoke to Phil Hand, Executive Chairman, Intelligent Fingerprinting.

Read More

Improving Gene Editing by Promoting Error-free Repair of CRISPR/Cas9-cut DNA
Industry Insight

With the first clinical trial of CRISPR gene editing in progress and the controversy of the first gene-edited babies continuing to spark discussion, it is more important than ever to better understand not only the benefits but also the risks of CRISPR-based therapies.

Read More

Antibody Tests To Detect SARS-CoV-2 Immune Status
Industry Insight

We recently spoke with Shamiram Feinglass, Global Chief Medical Officer at Beckman Coulter, to learn more about antibody tests, what they can tell us, and the value of this information.

Read More

More Sensitive COVID-19 Testing Using Droplet Digital PCR
Industry Insight

We recently spoke with experts at Bio-Rad to learn more about the reasons for, and significance of, false negative test results, and how the use of a more sensitive test could help to reduce this problem.

Read More

The Need for Broader Testing of COVID-19 Patients
Industry Insight

Diagnostic testing is playing a crucial role in global efforts to tackle the COVID-19 pandemic. By identifying infected individuals, efficient isolation and contact tracing can take place. However, what role could broader testing of COVID-19 patients have?

Read More

 
Advertisement